#6,864 by institutional money · Stock
Eloxx Pharmaceuticals, Inc. (ELOX)
Institutional ownership from Q3 2026 Form 13F filings
$10.65
+2.31% today
Market closed. Prices as of Nov 20, 7:41 AM ET
- 13F holders
- 20 (−2)
- Held by 13F filers, live
- $28.8M
- Shares held
- 2,700,412
- Share of stock outstanding
- 66.1%
- Net buying in Q3 2026
- −$2.1M
- New positions / sold out
- 3 / 5
Largest holders
20 investors| Investor | Shares | Value, live | % of their portfolio | vs Q2 2026 |
|---|---|---|---|---|
| Siren, L.L.C. | 400,000 | $4.3M | 0.11% | Unchanged |
| Samsara Biocapital, LLC | 400,000 | $4.3M | 0.47% | Unchanged |
| Aberdeen Group plc | 400,000 | $4.3M | <0.1% | Unchanged |
| EcoR1 Capital, LLC | 400,000 | $4.3M | 0.21% | Unchanged |
| Nantahala Capital Management, LLC | 400,000 | $4.3M | 0.26% | Reduced −50% |
| Stonepine Capital Management, LLC | 381,977 | $4.1M | 4.09% | Reduced −4% |
| Morgan Stanley | 202,630 | $2.2M | <0.1% | Added +13,024% |
| Vanguard Capital Management LLC | 78,680 | $838K | <0.1% | Unchanged |
| Geode Capital Management, LLC | 19,946 | $212K | <0.1% | New |
| Vanguard Fiduciary Trust Co | 13,669 | $146K | <0.1% | Added +29% |
| UBS Group AG | 2,026 | $22K | <0.1% | Added +218% |
| Vanguard Global Advisers, LLC | 718 | $8K | <0.1% | Unchanged |
| Tower Research Capital LLC (TRC) | 507 | $5K | <0.1% | New |
| Wells Fargo & Company/mn | 126 | $1K | <0.1% | Unchanged |
| Pioneer Family Office, LLC | 96 | $1K | <0.1% | Unchanged |
| Altshuler Shaham Ltd | 25 | $266 | <0.1% | Unchanged |
| Towne Trust Company, N.A | 5 | $53 | <0.1% | Unchanged |
| Activest Wealth Management | 4 | $43 | <0.1% | Unchanged |
| SBI Securities Co., Ltd. | 2 | $21 | <0.1% | Unchanged |
| National Bank Of Canada /fi/ | 1 | $11 | <0.1% | New |